Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tonsilotren
- Development stage
- Phase 3
- Lead developer
- Deutsche Homöopathie-Union
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tonsilotren (SilAtro-5-90) is a complex homeopathic medicinal product developed by Deutsche Homöopathie-Union (DHU) for the treatment of inflammatory conditions of the throat. It is a fixed-dose combination of five homeopathic ingredients: Atropinum sulfuricum, Hepar sulfuris, Kalium bichromicum, Silicea, and Mercurius bijodatus. The drug is indicated for acute and chronic tonsillitis (including catarrhal, lacunar, and follicular forms), enlargement of the tonsils in childhood, and as an adjunct therapy to accelerate healing of the pharyngeal mucosa after tonsillectomy. It is formulated as oral tablets/lozenges and is intended to exert anti-inflammatory effects, stimulate tissue regeneration, and support local immunity. Tonsilotren has been evaluated in a Phase III international, pragmatic, randomized controlled clinical trial (ISRCTN19016626) for chronic/recurrent tonsillitis, demonstrating efficacy in reducing the frequency and severity of episodes over a 60-week observation period.
- Brand names
- Tonsilotren
Beyond the preview
Go deeper on Tonsilotren.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tonsilotren.